カテゴリー： 世界, 医療/バイオ, LP Information

世界のスコポラミン臭化ブチルカプセル市場予測 2023年-2029年

【英語タイトル】Global Scopolamine Butylbromide Capsules Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC11440）・商品コード：LP23DC11440
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：93
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のスコポラミン臭化ブチルカプセル市場」は、過去の販売実績から2022年の世界のスコポラミン臭化ブチルカプセルの総販売量を検討し、2023年から2029年の予測されるスコポラミン臭化ブチルカプセルの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のスコポラミン臭化ブチルカプセルの市場規模を掲載し、XXX百万米ドル規模の世界のスコポラミン臭化ブチルカプセル市場の詳細な分析を提供します。本インサイトレポートは、世界のスコポラミン臭化ブチルカプセル業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のスコポラミン臭化ブチルカプセル市場における各社の独自のポジションをより深く理解するために、スコポラミン臭化ブチルカプセル製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のスコポラミン臭化ブチルカプセル市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。スコポラミン臭化ブチルカプセルの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。スコポラミン臭化ブチルカプセルの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。スコポラミン臭化ブチルカプセルのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

スコポラミン臭化ブチルカプセルの世界主要メーカーとしては、AdvaCare Pharma、 Zuche Pharmaceuticals、 SHRI HARI ENTERPRISE、 Facmed Pharmaceuticals Private Limited、 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd、 Guangdong Huanan Pharmaceutical Group Co., Ltd、 Lodays Pharmaceutical(Hubei) Co.,Ltd、 Chengdu First Pharmaceutical Co., Ltd、 Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltdなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のスコポラミン臭化ブチルカプセル市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではスコポラミン臭化ブチルカプセル市場をセグメンテーションし、種類別 (12個/箱、24個/箱)、用途別 (胃腸けいれん＆運動亢進、胆道疝痛、腎疝痛、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：12個/箱、24個/箱

・用途別区分：胃腸けいれん＆運動亢進、胆道疝痛、腎疝痛、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のスコポラミン臭化ブチルカプセル市場の10年間の市場状況・展望は？
・世界および地域別に見たスコポラミン臭化ブチルカプセル市場成長の要因は何か？
・スコポラミン臭化ブチルカプセルの市場機会はエンドマーケットの規模によってどのように変化するのか？
・スコポラミン臭化ブチルカプセルのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：スコポラミン臭化ブチルカプセルの年間販売量2018-2029、地域別現状・将来分析
・スコポラミン臭化ブチルカプセルの種類別セグメント：12個/箱、24個/箱
・スコポラミン臭化ブチルカプセルの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・スコポラミン臭化ブチルカプセルの用途別セグメント：胃腸けいれん＆運動亢進、胆道疝痛、腎疝痛、その他
・スコポラミン臭化ブチルカプセルの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のスコポラミン臭化ブチルカプセル市場
・企業別のグローバルスコポラミン臭化ブチルカプセル市場データ：2018-2023年の年間販売量、市場シェア
・企業別のスコポラミン臭化ブチルカプセルの年間売上：2018-2023年の売上、市場シェア
・企業別のスコポラミン臭化ブチルカプセル販売価格
・主要企業のスコポラミン臭化ブチルカプセル生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

スコポラミン臭化ブチルカプセルの地域別レビュー
・地域別のスコポラミン臭化ブチルカプセル市場規模2018-2023：年間販売量、売上
・主要国別のスコポラミン臭化ブチルカプセル市場規模2018-2023：年間販売量、売上
・南北アメリカのスコポラミン臭化ブチルカプセル販売の成長
・アジア太平洋のスコポラミン臭化ブチルカプセル販売の成長
・ヨーロッパのスコポラミン臭化ブチルカプセル販売の成長
・中東・アフリカのスコポラミン臭化ブチルカプセル販売の成長

南北アメリカ市場
・南北アメリカの国別のスコポラミン臭化ブチルカプセル販売量、売上（2018-2023）
・南北アメリカのスコポラミン臭化ブチルカプセルの種類別販売量
・南北アメリカのスコポラミン臭化ブチルカプセルの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のスコポラミン臭化ブチルカプセル販売量、売上（2018-2023）
・アジア太平洋のスコポラミン臭化ブチルカプセルの種類別販売量
・アジア太平洋のスコポラミン臭化ブチルカプセルの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のスコポラミン臭化ブチルカプセル販売量、売上（2018-2023）
・ヨーロッパのスコポラミン臭化ブチルカプセルの種類別販売量
・ヨーロッパのスコポラミン臭化ブチルカプセルの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のスコポラミン臭化ブチルカプセル販売量、売上（2018-2023）
・中東・アフリカのスコポラミン臭化ブチルカプセルの種類別販売量
・中東・アフリカのスコポラミン臭化ブチルカプセルの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・スコポラミン臭化ブチルカプセルの製造コスト構造分析
・スコポラミン臭化ブチルカプセルの製造プロセス分析
・スコポラミン臭化ブチルカプセルの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・スコポラミン臭化ブチルカプセルの主要なグローバル販売業者
・スコポラミン臭化ブチルカプセルの主要なグローバル顧客

地域別のスコポラミン臭化ブチルカプセル市場予測レビュー
・地域別のスコポラミン臭化ブチルカプセル市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・スコポラミン臭化ブチルカプセルの種類別市場規模予測
・スコポラミン臭化ブチルカプセルの用途別市場規模予測

主要企業分析
AdvaCare Pharma、 Zuche Pharmaceuticals、 SHRI HARI ENTERPRISE、 Facmed Pharmaceuticals Private Limited、 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd、 Guangdong Huanan Pharmaceutical Group Co., Ltd、 Lodays Pharmaceutical(Hubei) Co.,Ltd、 Chengdu First Pharmaceutical Co., Ltd、 Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd
・企業情報
・スコポラミン臭化ブチルカプセル製品
・スコポラミン臭化ブチルカプセル販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Scopolamine Butylbromide Capsules market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Scopolamine Butylbromide Capsules is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Scopolamine Butylbromide Capsules is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Scopolamine Butylbromide Capsules is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Scopolamine Butylbromide Capsules players cover AdvaCare Pharma, Zuche Pharmaceuticals, SHRI HARI ENTERPRISE, Facmed Pharmaceuticals Private Limited, Guangzhou Baiyunshan Pharmaceutical Co.,Ltd, Guangdong Huanan Pharmaceutical Group Co., Ltd, Lodays Pharmaceutical(Hubei) Co.,Ltd, Chengdu First Pharmaceutical Co., Ltd and Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Scopolamine Butylbromide Capsules, the indications are 1. It is used for the preoperative preparation of stomach, duodenum and colon endoscopy, endoscopic retrograde cholangiopancreatography, and the preoperative preparation of gas barium hypotonia or abdominal CT scan of stomach, duodenum and colon. Reduce or inhibit gastrointestinal motility; 2. It is used for gastrointestinal spasm, biliary colic, renal colic or hyperperistalsis of gastrointestinal tract caused by various etiologies.
LPI (LP Information)’ newest research report, the “Scopolamine Butylbromide Capsules Industry Forecast” looks at past sales and reviews total world Scopolamine Butylbromide Capsules sales in 2022, providing a comprehensive analysis by region and market sector of projected Scopolamine Butylbromide Capsules sales for 2023 through 2029. With Scopolamine Butylbromide Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Scopolamine Butylbromide Capsules industry.
This Insight Report provides a comprehensive analysis of the global Scopolamine Butylbromide Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Scopolamine Butylbromide Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Scopolamine Butylbromide Capsules market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Scopolamine Butylbromide Capsules and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Scopolamine Butylbromide Capsules.
This report presents a comprehensive overview, market shares, and growth opportunities of Scopolamine Butylbromide Capsules market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
12 Pieces/Box
24 Pieces/Box
Segmentation by application
Gastrointestinal Spasm and Hypermotility
Biliary Colic
Renal Colic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
AdvaCare Pharma
Zuche Pharmaceuticals
SHRI HARI ENTERPRISE
Facmed Pharmaceuticals Private Limited
Guangzhou Baiyunshan Pharmaceutical Co.,Ltd
Guangdong Huanan Pharmaceutical Group Co., Ltd
Lodays Pharmaceutical(Hubei) Co.,Ltd
Chengdu First Pharmaceutical Co., Ltd
Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Scopolamine Butylbromide Capsules market?
What factors are driving Scopolamine Butylbromide Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Scopolamine Butylbromide Capsules market opportunities vary by end market size?
How does Scopolamine Butylbromide Capsules break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Scopolamine Butylbromide Capsules Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Scopolamine Butylbromide Capsules by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Scopolamine Butylbromide Capsules by Country/Region, 2018, 2022 & 2029
2.2 Scopolamine Butylbromide Capsules Segment by Type
2.2.1 12 Pieces/Box
2.2.2 24 Pieces/Box
2.3 Scopolamine Butylbromide Capsules Sales by Type
2.3.1 Global Scopolamine Butylbromide Capsules Sales Market Share by Type (2018-2023)
2.3.2 Global Scopolamine Butylbromide Capsules Revenue and Market Share by Type (2018-2023)
2.3.3 Global Scopolamine Butylbromide Capsules Sale Price by Type (2018-2023)
2.4 Scopolamine Butylbromide Capsules Segment by Application
2.4.1 Gastrointestinal Spasm and Hypermotility
2.4.2 Biliary Colic
2.4.3 Renal Colic
2.4.4 Others
2.5 Scopolamine Butylbromide Capsules Sales by Application
2.5.1 Global Scopolamine Butylbromide Capsules Sale Market Share by Application (2018-2023)
2.5.2 Global Scopolamine Butylbromide Capsules Revenue and Market Share by Application (2018-2023)
2.5.3 Global Scopolamine Butylbromide Capsules Sale Price by Application (2018-2023)
3 Global Scopolamine Butylbromide Capsules by Company
3.1 Global Scopolamine Butylbromide Capsules Breakdown Data by Company
3.1.1 Global Scopolamine Butylbromide Capsules Annual Sales by Company (2018-2023)
3.1.2 Global Scopolamine Butylbromide Capsules Sales Market Share by Company (2018-2023)
3.2 Global Scopolamine Butylbromide Capsules Annual Revenue by Company (2018-2023)
3.2.1 Global Scopolamine Butylbromide Capsules Revenue by Company (2018-2023)
3.2.2 Global Scopolamine Butylbromide Capsules Revenue Market Share by Company (2018-2023)
3.3 Global Scopolamine Butylbromide Capsules Sale Price by Company
3.4 Key Manufacturers Scopolamine Butylbromide Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Scopolamine Butylbromide Capsules Product Location Distribution
3.4.2 Players Scopolamine Butylbromide Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Scopolamine Butylbromide Capsules by Geographic Region
4.1 World Historic Scopolamine Butylbromide Capsules Market Size by Geographic Region (2018-2023)
4.1.1 Global Scopolamine Butylbromide Capsules Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Scopolamine Butylbromide Capsules Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Scopolamine Butylbromide Capsules Market Size by Country/Region (2018-2023)
4.2.1 Global Scopolamine Butylbromide Capsules Annual Sales by Country/Region (2018-2023)
4.2.2 Global Scopolamine Butylbromide Capsules Annual Revenue by Country/Region (2018-2023)
4.3 Americas Scopolamine Butylbromide Capsules Sales Growth
4.4 APAC Scopolamine Butylbromide Capsules Sales Growth
4.5 Europe Scopolamine Butylbromide Capsules Sales Growth
4.6 Middle East & Africa Scopolamine Butylbromide Capsules Sales Growth
5 Americas
5.1 Americas Scopolamine Butylbromide Capsules Sales by Country
5.1.1 Americas Scopolamine Butylbromide Capsules Sales by Country (2018-2023)
5.1.2 Americas Scopolamine Butylbromide Capsules Revenue by Country (2018-2023)
5.2 Americas Scopolamine Butylbromide Capsules Sales by Type
5.3 Americas Scopolamine Butylbromide Capsules Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Scopolamine Butylbromide Capsules Sales by Region
6.1.1 APAC Scopolamine Butylbromide Capsules Sales by Region (2018-2023)
6.1.2 APAC Scopolamine Butylbromide Capsules Revenue by Region (2018-2023)
6.2 APAC Scopolamine Butylbromide Capsules Sales by Type
6.3 APAC Scopolamine Butylbromide Capsules Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Scopolamine Butylbromide Capsules by Country
7.1.1 Europe Scopolamine Butylbromide Capsules Sales by Country (2018-2023)
7.1.2 Europe Scopolamine Butylbromide Capsules Revenue by Country (2018-2023)
7.2 Europe Scopolamine Butylbromide Capsules Sales by Type
7.3 Europe Scopolamine Butylbromide Capsules Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Scopolamine Butylbromide Capsules by Country
8.1.1 Middle East & Africa Scopolamine Butylbromide Capsules Sales by Country (2018-2023)
8.1.2 Middle East & Africa Scopolamine Butylbromide Capsules Revenue by Country (2018-2023)
8.2 Middle East & Africa Scopolamine Butylbromide Capsules Sales by Type
8.3 Middle East & Africa Scopolamine Butylbromide Capsules Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Scopolamine Butylbromide Capsules
10.3 Manufacturing Process Analysis of Scopolamine Butylbromide Capsules
10.4 Industry Chain Structure of Scopolamine Butylbromide Capsules
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Scopolamine Butylbromide Capsules Distributors
11.3 Scopolamine Butylbromide Capsules Customer
12 World Forecast Review for Scopolamine Butylbromide Capsules by Geographic Region
12.1 Global Scopolamine Butylbromide Capsules Market Size Forecast by Region
12.1.1 Global Scopolamine Butylbromide Capsules Forecast by Region (2024-2029)
12.1.2 Global Scopolamine Butylbromide Capsules Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Scopolamine Butylbromide Capsules Forecast by Type
12.7 Global Scopolamine Butylbromide Capsules Forecast by Application
13 Key Players Analysis
13.1 AdvaCare Pharma
13.1.1 AdvaCare Pharma Company Information
13.1.2 AdvaCare Pharma Scopolamine Butylbromide Capsules Product Portfolios and Specifications
13.1.3 AdvaCare Pharma Scopolamine Butylbromide Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AdvaCare Pharma Main Business Overview
13.1.5 AdvaCare Pharma Latest Developments
13.2 Zuche Pharmaceuticals
13.2.1 Zuche Pharmaceuticals Company Information
13.2.2 Zuche Pharmaceuticals Scopolamine Butylbromide Capsules Product Portfolios and Specifications
13.2.3 Zuche Pharmaceuticals Scopolamine Butylbromide Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Zuche Pharmaceuticals Main Business Overview
13.2.5 Zuche Pharmaceuticals Latest Developments
13.3 SHRI HARI ENTERPRISE
13.3.1 SHRI HARI ENTERPRISE Company Information
13.3.2 SHRI HARI ENTERPRISE Scopolamine Butylbromide Capsules Product Portfolios and Specifications
13.3.3 SHRI HARI ENTERPRISE Scopolamine Butylbromide Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 SHRI HARI ENTERPRISE Main Business Overview
13.3.5 SHRI HARI ENTERPRISE Latest Developments
13.4 Facmed Pharmaceuticals Private Limited
13.4.1 Facmed Pharmaceuticals Private Limited Company Information
13.4.2 Facmed Pharmaceuticals Private Limited Scopolamine Butylbromide Capsules Product Portfolios and Specifications
13.4.3 Facmed Pharmaceuticals Private Limited Scopolamine Butylbromide Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Facmed Pharmaceuticals Private Limited Main Business Overview
13.4.5 Facmed Pharmaceuticals Private Limited Latest Developments
13.5 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd
13.5.1 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd Company Information
13.5.2 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd Scopolamine Butylbromide Capsules Product Portfolios and Specifications
13.5.3 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd Scopolamine Butylbromide Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd Main Business Overview
13.5.5 Guangzhou Baiyunshan Pharmaceutical Co.,Ltd Latest Developments
13.6 Guangdong Huanan Pharmaceutical Group Co., Ltd
13.6.1 Guangdong Huanan Pharmaceutical Group Co., Ltd Company Information
13.6.2 Guangdong Huanan Pharmaceutical Group Co., Ltd Scopolamine Butylbromide Capsules Product Portfolios and Specifications
13.6.3 Guangdong Huanan Pharmaceutical Group Co., Ltd Scopolamine Butylbromide Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Guangdong Huanan Pharmaceutical Group Co., Ltd Main Business Overview
13.6.5 Guangdong Huanan Pharmaceutical Group Co., Ltd Latest Developments
13.7 Lodays Pharmaceutical(Hubei) Co.,Ltd
13.7.1 Lodays Pharmaceutical(Hubei) Co.,Ltd Company Information
13.7.2 Lodays Pharmaceutical(Hubei) Co.,Ltd Scopolamine Butylbromide Capsules Product Portfolios and Specifications
13.7.3 Lodays Pharmaceutical(Hubei) Co.,Ltd Scopolamine Butylbromide Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Lodays Pharmaceutical(Hubei) Co.,Ltd Main Business Overview
13.7.5 Lodays Pharmaceutical(Hubei) Co.,Ltd Latest Developments
13.8 Chengdu First Pharmaceutical Co., Ltd
13.8.1 Chengdu First Pharmaceutical Co., Ltd Company Information
13.8.2 Chengdu First Pharmaceutical Co., Ltd Scopolamine Butylbromide Capsules Product Portfolios and Specifications
13.8.3 Chengdu First Pharmaceutical Co., Ltd Scopolamine Butylbromide Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Chengdu First Pharmaceutical Co., Ltd Main Business Overview
13.8.5 Chengdu First Pharmaceutical Co., Ltd Latest Developments
13.9 Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd
13.9.1 Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd Company Information
13.9.2 Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd Scopolamine Butylbromide Capsules Product Portfolios and Specifications
13.9.3 Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd Scopolamine Butylbromide Capsules Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd Main Business Overview
13.9.5 Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Scopolamine Butylbromide Capsules Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Scopolamine Butylbromide Capsules Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 12 Pieces/Box
Table 4. Major Players of 24 Pieces/Box
Table 5. Global Scopolamine Butylbromide Capsules Sales by Type (2018-2023) & (K Units)
Table 6. Global Scopolamine Butylbromide Capsules Sales Market Share by Type (2018-2023)
Table 7. Global Scopolamine Butylbromide Capsules Revenue by Type (2018-2023) & ($ million)
Table 8. Global Scopolamine Butylbromide Capsules Revenue Market Share by Type (2018-2023)
Table 9. Global Scopolamine Butylbromide Capsules Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Scopolamine Butylbromide Capsules Sales by Application (2018-2023) & (K Units)
Table 11. Global Scopolamine Butylbromide Capsules Sales Market Share by Application (2018-2023)
Table 12. Global Scopolamine Butylbromide Capsules Revenue by Application (2018-2023)
Table 13. Global Scopolamine Butylbromide Capsules Revenue Market Share by Application (2018-2023)
Table 14. Global Scopolamine Butylbromide Capsules Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Scopolamine Butylbromide Capsules Sales by Company (2018-2023) & (K Units)
Table 16. Global Scopolamine Butylbromide Capsules Sales Market Share by Company (2018-2023)
Table 17. Global Scopolamine Butylbromide Capsules Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Scopolamine Butylbromide Capsules Revenue Market Share by Company (2018-2023)
Table 19. Global Scopolamine Butylbromide Capsules Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Scopolamine Butylbromide Capsules Producing Area Distribution and Sales Area
Table 21. Players Scopolamine Butylbromide Capsules Products Offered
Table 22. Scopolamine Butylbromide Capsules Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Scopolamine Butylbromide Capsules Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Scopolamine Butylbromide Capsules Sales Market Share Geographic Region (2018-2023)
Table 27. Global Scopolamine Butylbromide Capsules Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Scopolamine Butylbromide Capsules Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Scopolamine Butylbromide Capsules Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Scopolamine Butylbromide Capsules Sales Market Share by Country/Region (2018-2023)
Table 31. Global Scopolamine Butylbromide Capsules Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Scopolamine Butylbromide Capsules Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Scopolamine Butylbromide Capsules Sales by Country (2018-2023) & (K Units)
Table 34. Americas Scopolamine Butylbromide Capsules Sales Market Share by Country (2018-2023)
Table 35. Americas Scopolamine Butylbromide Capsules Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Scopolamine Butylbromide Capsules Revenue Market Share by Country (2018-2023)
Table 37. Americas Scopolamine Butylbromide Capsules Sales by Type (2018-2023) & (K Units)
Table 38. Americas Scopolamine Butylbromide Capsules Sales by Application (2018-2023) & (K Units)
Table 39. APAC Scopolamine Butylbromide Capsules Sales by Region (2018-2023) & (K Units)
Table 40. APAC Scopolamine Butylbromide Capsules Sales Market Share by Region (2018-2023)
Table 41. APAC Scopolamine Butylbromide Capsules Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Scopolamine Butylbromide Capsules Revenue Market Share by Region (2018-2023)
Table 43. APAC Scopolamine Butylbromide Capsules Sales by Type (2018-2023) & (K Units)
Table 44. APAC Scopolamine Butylbromide Capsules Sales by Application (2018-2023) & (K Units)
Table 45. Europe Scopolamine Butylbromide Capsules Sales by Country (2018-2023) & (K Units)
Table 46. Europe Scopolamine Butylbromide Capsules Sales Market Share by Country (2018-2023)
Table 47. Europe Scopolamine Butylbromide Capsules Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Scopolamine Butylbromide Capsules Revenue Market Share by Country (2018-2023)
Table 49. Europe Scopolamine Butylbromide Capsules Sales by Type (2018-2023) & (K Units)
Table 50. Europe Scopolamine Butylbromide Capsules Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Scopolamine Butylbromide Capsules Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Scopolamine Butylbromide Capsules Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Scopolamine Butylbromide Capsules Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Scopolamine Butylbromide Capsules Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Scopolamine Butylbromide Capsules Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Scopolamine Butylbromide Capsules Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Scopolamine Butylbromide Capsules
Table 58. Key Market Challenges & Risks of Scopolamine Butylbromide Capsules
Table 59. Key Industry Trends of Scopolamine Butylbromide Capsules
Table 60. Scopolamine Butylbromide Capsules Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Scopolamine Butylbromide Capsules Distributors List
Table 63. Scopolamine Butylbromide Capsules Customer List
Table 64. Global Scopolamine Butylbromide Capsules Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Scopolamine Butylbromide Capsules Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Scopolamine Butylbromide Capsules Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Scopolamine Butylbromide Capsules Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Scopolamine Butylbromide Capsules Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Scopolamine Butylbromide Capsules Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Scopolamine Butylbromide Capsules Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Scopolamine Butylbromide Capsules Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Scopolamine Butylbromide Capsules Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Scopolamine Butylbromide Capsules Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Scopolamine Butylbromide Capsules Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Scopolamine Butylbromide Capsules Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Scopolamine Butylbromide Capsules Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Scopolamine Butylbromide Capsules Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AdvaCare Pharma Basic Information, Scopolamine Butylbromide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 79. AdvaCare Pharma Scopolamine Butylbromide Capsules Product Portfolios and Specifications
Table 80. AdvaCare Pharma Scopolamine Butylbromide Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. AdvaCare Pharma Main Business
Table 82. AdvaCare Pharma Latest Developments
Table 83. Zuche Pharmaceuticals Basic Information, Scopolamine Butylbromide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 84. Zuche Pharmaceuticals Scopolamine Butylbromide Capsules Product Portfolios and Specifications
Table 85. Zuche Pharmaceuticals Scopolamine Butylbromide Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Zuche Pharmaceuticals Main Business
Table 87. Zuche Pharmaceuticals Latest Developments
Table 88. SHRI HARI ENTERPRISE Basic Information, Scopolamine Butylbromide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 89. SHRI HARI ENTERPRISE Scopolamine Butylbromide Capsules Product Portfolios and Specifications
Table 90. SHRI HARI ENTERPRISE Scopolamine Butylbromide Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. SHRI HARI ENTERPRISE Main Business
Table 92. SHRI HARI ENTERPRISE Latest Developments
Table 93. Facmed Pharmaceuticals Private Limited Basic Information, Scopolamine Butylbromide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 94. Facmed Pharmaceuticals Private Limited Scopolamine Butylbromide Capsules Product Portfolios and Specifications
Table 95. Facmed Pharmaceuticals Private Limited Scopolamine Butylbromide Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Facmed Pharmaceuticals Private Limited Main Business
Table 97. Facmed Pharmaceuticals Private Limited Latest Developments
Table 98. Guangzhou Baiyunshan Pharmaceutical Co.,Ltd Basic Information, Scopolamine Butylbromide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 99. Guangzhou Baiyunshan Pharmaceutical Co.,Ltd Scopolamine Butylbromide Capsules Product Portfolios and Specifications
Table 100. Guangzhou Baiyunshan Pharmaceutical Co.,Ltd Scopolamine Butylbromide Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Guangzhou Baiyunshan Pharmaceutical Co.,Ltd Main Business
Table 102. Guangzhou Baiyunshan Pharmaceutical Co.,Ltd Latest Developments
Table 103. Guangdong Huanan Pharmaceutical Group Co., Ltd Basic Information, Scopolamine Butylbromide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 104. Guangdong Huanan Pharmaceutical Group Co., Ltd Scopolamine Butylbromide Capsules Product Portfolios and Specifications
Table 105. Guangdong Huanan Pharmaceutical Group Co., Ltd Scopolamine Butylbromide Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Guangdong Huanan Pharmaceutical Group Co., Ltd Main Business
Table 107. Guangdong Huanan Pharmaceutical Group Co., Ltd Latest Developments
Table 108. Lodays Pharmaceutical(Hubei) Co.,Ltd Basic Information, Scopolamine Butylbromide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 109. Lodays Pharmaceutical(Hubei) Co.,Ltd Scopolamine Butylbromide Capsules Product Portfolios and Specifications
Table 110. Lodays Pharmaceutical(Hubei) Co.,Ltd Scopolamine Butylbromide Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Lodays Pharmaceutical(Hubei) Co.,Ltd Main Business
Table 112. Lodays Pharmaceutical(Hubei) Co.,Ltd Latest Developments
Table 113. Chengdu First Pharmaceutical Co., Ltd Basic Information, Scopolamine Butylbromide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 114. Chengdu First Pharmaceutical Co., Ltd Scopolamine Butylbromide Capsules Product Portfolios and Specifications
Table 115. Chengdu First Pharmaceutical Co., Ltd Scopolamine Butylbromide Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Chengdu First Pharmaceutical Co., Ltd Main Business
Table 117. Chengdu First Pharmaceutical Co., Ltd Latest Developments
Table 118. Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd Basic Information, Scopolamine Butylbromide Capsules Manufacturing Base, Sales Area and Its Competitors
Table 119. Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd Scopolamine Butylbromide Capsules Product Portfolios and Specifications
Table 120. Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd Scopolamine Butylbromide Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd Main Business
Table 122. Guangzhou Hanfang Modern Chinese Medicine Research and Development Co., Ltd Latest Developments
List of Figures
Figure 1. Picture of Scopolamine Butylbromide Capsules
Figure 2. Scopolamine Butylbromide Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Scopolamine Butylbromide Capsules Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Scopolamine Butylbromide Capsules Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Scopolamine Butylbromide Capsules Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 12 Pieces/Box
Figure 10. Product Picture of 24 Pieces/Box
Figure 11. Global Scopolamine Butylbromide Capsules Sales Market Share by Type in 2022
Figure 12. Global Scopolamine Butylbromide Capsules Revenue Market Share by Type (2018-2023)
Figure 13. Scopolamine Butylbromide Capsules Consumed in Gastrointestinal Spasm and Hypermotility
Figure 14. Global Scopolamine Butylbromide Capsules Market: Gastrointestinal Spasm and Hypermotility (2018-2023) & (K Units)
Figure 15. Scopolamine Butylbromide Capsules Consumed in Biliary Colic
Figure 16. Global Scopolamine Butylbromide Capsules Market: Biliary Colic (2018-2023) & (K Units)
Figure 17. Scopolamine Butylbromide Capsules Consumed in Renal Colic
Figure 18. Global Scopolamine Butylbromide Capsules Market: Renal Colic (2018-2023) & (K Units)
Figure 19. Scopolamine Butylbromide Capsules Consumed in Others
Figure 20. Global Scopolamine Butylbromide Capsules Market: Others (2018-2023) & (K Units)
Figure 21. Global Scopolamine Butylbromide Capsules Sales Market Share by Application (2022)
Figure 22. Global Scopolamine Butylbromide Capsules Revenue Market Share by Application in 2022
Figure 23. Scopolamine Butylbromide Capsules Sales Market by Company in 2022 (K Units)
Figure 24. Global Scopolamine Butylbromide Capsules Sales Market Share by Company in 2022
Figure 25. Scopolamine Butylbromide Capsules Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Scopolamine Butylbromide Capsules Revenue Market Share by Company in 2022
Figure 27. Global Scopolamine Butylbromide Capsules Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Scopolamine Butylbromide Capsules Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Scopolamine Butylbromide Capsules Sales 2018-2023 (K Units)
Figure 30. Americas Scopolamine Butylbromide Capsules Revenue 2018-2023 ($ Millions)
Figure 31. APAC Scopolamine Butylbromide Capsules Sales 2018-2023 (K Units)
Figure 32. APAC Scopolamine Butylbromide Capsules Revenue 2018-2023 ($ Millions)
Figure 33. Europe Scopolamine Butylbromide Capsules Sales 2018-2023 (K Units)
Figure 34. Europe Scopolamine Butylbromide Capsules Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Scopolamine Butylbromide Capsules Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Scopolamine Butylbromide Capsules Revenue 2018-2023 ($ Millions)
Figure 37. Americas Scopolamine Butylbromide Capsules Sales Market Share by Country in 2022
Figure 38. Americas Scopolamine Butylbromide Capsules Revenue Market Share by Country in 2022
Figure 39. Americas Scopolamine Butylbromide Capsules Sales Market Share by Type (2018-2023)
Figure 40. Americas Scopolamine Butylbromide Capsules Sales Market Share by Application (2018-2023)
Figure 41. United States Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Scopolamine Butylbromide Capsules Sales Market Share by Region in 2022
Figure 46. APAC Scopolamine Butylbromide Capsules Revenue Market Share by Regions in 2022
Figure 47. APAC Scopolamine Butylbromide Capsules Sales Market Share by Type (2018-2023)
Figure 48. APAC Scopolamine Butylbromide Capsules Sales Market Share by Application (2018-2023)
Figure 49. China Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Scopolamine Butylbromide Capsules Sales Market Share by Country in 2022
Figure 57. Europe Scopolamine Butylbromide Capsules Revenue Market Share by Country in 2022
Figure 58. Europe Scopolamine Butylbromide Capsules Sales Market Share by Type (2018-2023)
Figure 59. Europe Scopolamine Butylbromide Capsules Sales Market Share by Application (2018-2023)
Figure 60. Germany Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Scopolamine Butylbromide Capsules Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Scopolamine Butylbromide Capsules Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Scopolamine Butylbromide Capsules Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Scopolamine Butylbromide Capsules Sales Market Share by Application (2018-2023)
Figure 69. Egypt Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Scopolamine Butylbromide Capsules Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Scopolamine Butylbromide Capsules in 2022
Figure 75. Manufacturing Process Analysis of Scopolamine Butylbromide Capsules
Figure 76. Industry Chain Structure of Scopolamine Butylbromide Capsules
Figure 77. Channels of Distribution
Figure 78. Global Scopolamine Butylbromide Capsules Sales Market Forecast by Region (2024-2029)
Figure 79. Global Scopolamine Butylbromide Capsules Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Scopolamine Butylbromide Capsules Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Scopolamine Butylbromide Capsules Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Scopolamine Butylbromide Capsules Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Scopolamine Butylbromide Capsules Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のスコポラミン臭化ブチルカプセル市場予測 2023年-2029年] (コード：LP23DC11440)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のスコポラミン臭化ブチルカプセル市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のホスネツピタント＆塩酸パロノセトロンカプセル市場予測 2023年-2029年
  • 世界のスクアレンカプセル市場予測 2023年-2029年
  • 世界のタムスロシン塩酸塩徐放性カプセル市場予測 2023年-2029年
  • 世界のニロチニブカプセル市場予測 2023年-2029年
  • 世界のラベプラゾールナトリウム腸溶コーティングカプセル市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆